Prelude Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,282
Closed -$1.74M 971
2025
Q1
$1.74M Buy
+8,282
New +$1.74M 0.13% 147
2024
Q4
Sell
-5,566
Closed -$1.1M 1050
2024
Q3
$1.1M Buy
+5,566
New +$1.1M 0.07% 312
2022
Q3
Sell
-2,526
Closed -$387K 1452
2022
Q2
$387K Sell
2,526
-136
-5% -$20.8K 0.01% 794
2022
Q1
$432K Sell
2,662
-3,736
-58% -$606K 0.01% 733
2021
Q4
$866K Buy
+6,398
New +$866K 0.02% 523
2021
Q3
Sell
-23,730
Closed -$2.67M 1308
2021
Q2
$2.67M Buy
+23,730
New +$2.67M 0.08% 158
2021
Q1
Sell
-1,880
Closed -$201K 1068
2020
Q4
$201K Sell
1,880
-10,251
-85% -$1.1M 0.01% 668
2020
Q3
$1.06M Buy
+12,131
New +$1.06M 0.05% 153
2020
Q2
Hold
0
1286
2020
Q1
Hold
0
906
2019
Q4
Hold
0
1369
2019
Q3
Hold
0
1144
2019
Q2
Sell
-26,783
Closed -$2.16M 1195
2019
Q1
$2.16M Buy
26,783
+15,827
+144% +$1.28M 0.12% 73
2018
Q4
$1.01M Buy
+10,956
New +$1.01M 0.07% 193
2018
Q2
Sell
-346
Closed -$33K 1322
2018
Q1
$33K Sell
346
-6,544
-95% -$624K ﹤0.01% 1042
2017
Q4
$666K Buy
+6,890
New +$666K 0.05% 299
2017
Q3
Sell
-7,422
Closed -$538K 1449
2017
Q2
$538K Buy
7,422
+6,807
+1,107% +$493K 0.05% 278
2017
Q1
$40K Buy
+615
New +$40K ﹤0.01% 1034
2016
Q4
Sell
-2,061
Closed -$130K 1460
2016
Q3
$130K Buy
+2,061
New +$130K 0.01% 675
2016
Q2
Sell
-9,125
Closed -$521K 1487
2016
Q1
$521K Sell
9,125
-2,572
-22% -$147K 0.07% 263
2015
Q4
$693K Buy
11,697
+905
+8% +$53.6K 0.11% 189
2015
Q3
$587K Buy
10,792
+4,051
+60% +$220K 0.09% 216
2015
Q2
$453K Sell
6,741
-16,611
-71% -$1.12M 0.06% 309
2015
Q1
$1.37M Buy
+23,352
New +$1.37M 0.19% 128
2014
Q2
Hold
0
1692
2014
Q1
Hold
0
1622